Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
EditorialEditorial

Using triple radio-immunotherapy to overcome cancer immunotherapy resistance

Zengfu Zhang, Xiaodong Zhang and Dawei Chen
Cancer Biology & Medicine November 2023, 20 (11) 788-794; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0268
Zengfu Zhang
1Department of Radiation Oncology, Shandong University Cancer Center, Jinan 250117, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaodong Zhang
2Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dawei Chen
1Department of Radiation Oncology, Shandong University Cancer Center, Jinan 250117, China
2Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dawei Chen
  • For correspondence: dave0505{at}yeah.net
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 20 no. 11 788-794
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2023.0268
PubMed 
37975213

Published By 
Cancer Biology & Medicine
History 
  • Received July 20, 2023
  • Accepted October 16, 2023
  • Published online December 1, 2023.

Article Versions

  • previous version (November 16, 2023 - 04:39).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright: © 2023, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

Funding

  • National Natural Science Foundation of China

    82172676
  • Natural Science Foundation of Shandong

    ZR2021YQ52

This study was supported by grants from the National Natural Science Foundation of China (Grant No. 82172676) and the Natural Science Foundation of Shandong (Grant No. ZR2021YQ52).

PreviousNext
Back to top

In this issue

Cancer Biology & Medicine: 20 (11)
Cancer Biology & Medicine
Vol. 20, Issue 11
15 Nov 2023
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Using triple radio-immunotherapy to overcome cancer immunotherapy resistance
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Using triple radio-immunotherapy to overcome cancer immunotherapy resistance
Zengfu Zhang, Xiaodong Zhang, Dawei Chen
Cancer Biology & Medicine Nov 2023, 20 (11) 788-794; DOI: 10.20892/j.issn.2095-3941.2023.0268

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Using triple radio-immunotherapy to overcome cancer immunotherapy resistance
Zengfu Zhang, Xiaodong Zhang, Dawei Chen
Cancer Biology & Medicine Nov 2023, 20 (11) 788-794; DOI: 10.20892/j.issn.2095-3941.2023.0268
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Current status and challenges of iRT
    • Using LDIR and alternative immune targets to boost the efficacy of iRT
    • Perspectives
    • Conflict of interest statement
    • Author contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Multi-cancer early detection: from promise to practice and the next frontier
  • From overtreatment to precision: a new clinical standard for DCIS management
  • Gut microbiome: an emerging player and therapeutic target in cancer
Show more Editorial

Similar Articles

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire